How have RKAGY shares performed in 2024?

RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $5.4148 at the start of the year. Since then, RKAGY shares have increased by 11.7% and is now trading at $6.05. View the best growth stocks for 2024 here .

Are investors shorting RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 500 shares, an increase of 25.0% from the March 15th total of 400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 5.0 days. View RHÖN-KLINIKUM Aktiengesellschaft's Short Interest .

How often does RHÖN-KLINIKUM Aktiengesellschaft pay dividends? What is the dividend yield for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft declared a dividend on Friday, June 2nd. Stockholders of record on Friday, June 9th will be paid a dividend of $0.0522 per share on Wednesday, June 28th. This represents a dividend yield of 0.77%. The ex-dividend date of this dividend is Thursday, June 8th. Read our dividend analysis for RKAGY .

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?

RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.34%. RKAGY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for RKAGY .

How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft?

Shares of RKAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:RKAGY

RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Stock Price, News & Analysis

→ Elon Musk’s ChatGPT Could Soon Mint New Millionaires (From InvestorPlace) (Ad)

Free RKAGY Stock Alerts

$6.05

0.00 (0.00%)

(As of 04/15/2024 ET)

Compare

Today's Range: $6.05
▼
$6.05
50-Day Range: $5.41
▼
$6.51
52-Week Range: $5.41
▼
$6.51

Volume: N/A
Average Volume: 150 shs
Market Capitalization: N/A

P/E Ratio: 1.34
Dividend Yield: 1.36%
Price Target: N/A

Stock Analysis Chart Dividend Short Interest

Get RHÖN-KLINIKUM Aktiengesellschaft alerts:

RHÖN-KLINIKUM Aktiengesellschaft MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: -0.08
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: N/A

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.26 out of 5 stars

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for RHÖN-KLINIKUM Aktiengesellschaft.

1.0

Short Interest

Percentage of Shares Shorted
Short Interest Ratio / Days to Cover
RHÖN-KLINIKUM Aktiengesellschaft has a short interest ratio ("days to cover") of 5.
Change versus previous month
Short interest in RHÖN-KLINIKUM Aktiengesellschaft has recently increased by 25.00%, indicating that investor sentiment is decreasing significantly.

2.5

Dividend Strength

Dividend Leadership
RHÖN-KLINIKUM Aktiengesellschaft is a leading dividend payer. It pays a dividend yield of 5.34%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
RHÖN-KLINIKUM Aktiengesellschaft does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for RKAGY.

1.1

News and Social Media Coverage

News Sentiment
RHÖN-KLINIKUM Aktiengesellschaft has a news sentiment score of -0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for RHÖN-KLINIKUM Aktiengesellschaft this week, compared to 2 articles on an average week.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, RHÖN-KLINIKUM Aktiengesellschaft insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 0.17% of the stock of RHÖN-KLINIKUM Aktiengesellschaft is held by institutions.

1.3

Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.34, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.24.
Price to Earnings Ratio vs. Sector
The P/E ratio of RHÖN-KLINIKUM Aktiengesellschaft is 1.34, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 249.13.

See Top Rated MarketRank™ Stocks Here

Ad Porter & Company

The #1 Investment of the Decade…

Sam Altman, the CEO of OpenAI, has invested $375 million into a breakthrough technology, that legendary financial analyst Porter Stansberry believes… …could be the number-one investment of the decade.

To get all the details of this controversial tech – click here now.

About RHÖN-KLINIKUM Aktiengesellschaft Stock (OTCMKTS:RKAGY)

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation, ophthalmology, pregnancies and births, accident surgery, dentistry, tumors, neurological conditions, and treatment of thoracic, lung, vascular, nerves and the skeletal system, and heart diseases. The company was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

RKAGY Stock Price History

30 days | 90 days | 365 days | Advanced Chart

RKAGY Stock News Headlines

April 15, 2024 | americanbankingnews.com

RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) Sees Large Growth in Short Interest

See More Headlines

Receive RKAGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RHÖN-KLINIKUM Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Care Facilities
Sub-Industry: N/A
Current Symbol: OTCMKTS:RKAGY
CUSIP: N/A
CIK: N/A
Web: www.rhoen-klinikum-ag.com
Phone: 499771650
Fax: N/A
Employees: 18,158
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 1.34
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Dr. Tobias Kaltenbach (Age 64)
Chairman of Management Board
Comp: $592.5k
Dr. Stefan Stranz (Age 47)
CFO & Member of Management Board
Comp: $723.56k
Dr. Gunther Karl Weiß M.Sc. (Age 56)
COO & Member of Management Board
Comp: $766.89k
Julian Schmitt
Head of Investor Relations & Treasury
Mr. Eugen Münch
Chief Representative

Key Competitors

View All Competitors

RKAGY Stock Analysis - Frequently Asked Questions

How have RKAGY shares performed in 2024?: RHÖN-KLINIKUM Aktiengesellschaft's stock was trading at $5.4148 at the start of the year. Since then, RKAGY shares have increased by 11.7% and is now trading at $6.05.
View the best growth stocks for 2024 here.
Are investors shorting RHÖN-KLINIKUM Aktiengesellschaft?: RHÖN-KLINIKUM Aktiengesellschaft saw a increase in short interest during the month of March. As of March 31st, there was short interest totaling 500 shares, an increase of 25.0% from the March 15th total of 400 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 5.0 days.
View RHÖN-KLINIKUM Aktiengesellschaft's Short Interest.
How often does RHÖN-KLINIKUM Aktiengesellschaft pay dividends? What is the dividend yield for RHÖN-KLINIKUM Aktiengesellschaft?: RHÖN-KLINIKUM Aktiengesellschaft declared a dividend on Friday, June 2nd. Stockholders of record on Friday, June 9th will be paid a dividend of $0.0522 per share on Wednesday, June 28th. This represents a dividend yield of 0.77%. The ex-dividend date of this dividend is Thursday, June 8th.
Read our dividend analysis for RKAGY.

Is RHÖN-KLINIKUM Aktiengesellschaft a good dividend stock?: RHÖN-KLINIKUM Aktiengesellschaft (OTCMKTS:RKAGY) pays an annual dividend of $0.08 per share and currently has a dividend yield of 5.34%. RKAGY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 1.83%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for RKAGY.
How do I buy shares of RHÖN-KLINIKUM Aktiengesellschaft?: Shares of RKAGY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:RKAGY) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

RHÖN-KLINIKUM Aktiengesellschaft (RKAGY) Stock Price, News & Analysis